title: The cholinergic system of the preoptic-anterior hypothalamic areas regulates the ovarian follicular population in an asymmetric way.
abstract: Atropine implants in the preoptic-anterior hypothalamic areas (POA-AHA) block ovulation. The blocking effects depend on the side of POA-AHA and the day of the estrous cycle in which the implants are inserted. Since ovulation is the result of the growth and differentiation of ovarian follicles, the purpose of this study was to analyze the changes in follicular and atresia population in the ovaries of non-ovulating rats resulting from the unilateral atropine implants in the POA-AHA. Groups of cyclic rats were implanted with atropine or cholesterol (sham treatment group) in the left (diestrus-1, diestrus-2) or the right side (estrus, diestrus-1) of the POA-AHA. The animals were sacrificed on the expected proestrus or estrus day, and the follicular population was counted and the follicles measured in both ovaries. Atropine implants inserted in the left POA-AHA on diestrus-2 resulted in lower follicular growth and atresia in the ipsilateral ovary (left one). No apparent effects were observed in the right ovary. Atropine implants inserted in the right POA-AHA on estrus day resulted in fewer numbers of small follicles in the ipsilateral ovary (right) and a greater number of pre-ovulatory ones. Present results suggest that acetylcholine, via muscarinic receptors of the POA-AHA, regulates ovarian follicular fate in an asymmetric way, and that its actions fluctuate during the estrous cycle. In addition, each ovary seems to respond differently to the POA-AHA's muscarinic signal surge on estrus and diestrus-2 days.
authors.affiliation: Neuroendocrinology Laboratory, Biology of Reproduction Research Unit, Facultad de Estudios Superiores Zaragoza, UNAM, A. P. 9-020, 15000, Mexico, DF, Mexico, mecbloy@yahoo.com.mx.
authors.forename: María Esther
authors.initials: ME
authors.lastname: Cruz
authors.forename: Angélica
authors.initials: A
authors.lastname: Flores
authors.forename: Roberto
authors.initials: R
authors.lastname: Domínguez
mesh_terms: D000818:Animals; D007025:Anterior Hypothalamic Nucleus / Q000187:drug effects / Q000378:metabolism*; D001285:Atropine / Q000494:pharmacology; D059329:Cholinergic Neurons / Q000187:drug effects / Q000378:metabolism*; D030762:Estrous Cycle / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D018727:Muscarinic Antagonists / Q000494:pharmacology; D006080:Ovarian Follicle / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D011301:Preoptic Area / Q000187:drug effects / Q000378:metabolism*; D051381:Rats
chemical_list: D018727:Muscarinic Antagonists; D001285:Atropine
references.citation: Microsc Res Tech. 2007 Aug;70(8):710-8
references.pmid: 17393475
references.citation: J Neurovisc Relat. 1971;32(3):241-8
references.pmid: 5107096
references.citation: Neuroendocrinology. 1985 Oct;41(4):321-31
references.pmid: 2995860
references.citation: Gen Comp Endocrinol. 2010 Mar 1;166(1):39-46
references.pmid: 19896947
references.citation: Brain Res Bull. 1983 Mar;10(3):353-5
references.pmid: 6405979
references.citation: Neurosci Lett. 1984 Oct 26;51(3):365-70
references.pmid: 6441131
references.citation: Biol Reprod. 1979 Mar;20(2):261-8
references.pmid: 454737
references.citation: Rev Invest Clin. 1986 Apr-Jun;38(2):167-71
references.pmid: 3090668
references.citation: Horm Behav. 1997 Dec;32(3):217-25
references.pmid: 9454673
references.citation: Neuropharmacology. 2010 Jun;58(7):1161-7
references.pmid: 20170666
references.citation: Experientia. 1970 Nov 15;26(11):1263-4
references.pmid: 5485309
references.citation: Biol Reprod. 2008 Mar;78(3):380-9
references.pmid: 18003945
references.citation: Endocrinology. 1974 Nov;95(5):1373-9
references.pmid: 4609755
references.citation: Clinics (Sao Paulo). 2011;66(9):1605-10
references.pmid: 22179167
references.citation: Brain Res Bull. 2001 Mar 1;54(4):339-44
references.pmid: 11306184
references.citation: Life Sci. 2003 Sep 5;73(16):2113-25
references.pmid: 12899934
references.citation: J Endocrinol. 1982 Nov;95(2):175-80
references.pmid: 6890978
references.citation: Arch Med Res. 1997 Autumn;28(3):343-8
references.pmid: 9291628
references.citation: Biol Reprod. 1978 Oct;19(3):597-605
references.pmid: 363183
references.citation: J Endocrinol. 1992 May;133(2):205-10
references.pmid: 1613423
references.citation: Endocrinology. 1971 Feb;88(2):293-301
references.pmid: 5099695
references.citation: Brain Res Bull. 1982 Mar;8(3):299-302
references.pmid: 6807493
references.citation: Brain Res. 1988 Mar 8;443(1-2):21-6
references.pmid: 2896055
references.citation: Brain Res Bull. 2008 Nov 25;77(5):306-11
references.pmid: 18817853
references.citation: Neuroendocrinology. 1975;18(4):322-32
references.pmid: 765884
references.citation: Endocrine. 2009 Oct;36(2):179-88
references.pmid: 19418269
references.citation: Proc Soc Exp Biol Med. 1974 Nov;147(2):498-504
references.pmid: 4612554
references.citation: Mol Cell Endocrinol. 1992 Dec;90(1):87-93
references.pmid: 1363791
references.citation: Neurochem Int. 2008 Mar-Apr;52(4-5):723-8
references.pmid: 17933433
references.citation: J Endocrinol. 1989 Dec;123(3):437-9
references.pmid: 2607252